CorMedix Inc.
CRMDNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $689.89M
- P/E (TTM)
- 3.69
- Forward P/E
- 1.82
- Dividend yield
- -
- 52-week range
- $6.13$13.02
- Volume (live)
- -
- Avg. volume (3M)
- 972.10K
CorMedix (CRMD) Stock Price & Financial Analysis
CorMedix Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.24 - $7.47 |
|---|---|
| 52-Week High | $13.02 |
| 52-Week Low | $6.13 |
| Open | $7.47 |
| Volume (last close) | 1.14M |
| Average Volume (3M) | 972.10K |
| Revenue (TTM) | 462.25M |
|---|---|
| Net Income (TTM) | 187.17M |
| Free Cash Flow (TTM) | 250.42M |
| EPS (TTM) | $2.05 |
| Profit Margin | 40.49% |
| Operating Margin | 46.95% |
| Return on Equity (ROE) | 40.62% |
| Debt to Equity | 0.31 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 689.89M |
|---|---|
| Shares Outstanding | 92.48M |
| P/E Ratio (TTM) | 3.69 |
| Forward P/E | 1.82 |
| Price to Sales (P/S) | 1.49 |
| Price to Book (P/B) | 1.50 |
| EV/EBITDA | 2.35 |
| 50-Day MA | $7.83 |
|---|---|
| 200-Day MA | $7.82 |
| 1-Year Change | −26.72% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
CorMedix at a Glance
As of the Oct 16, 2026 close, CorMedix (CRMD) has a market capitalization of $689.89M. The stock trades at 3.7× trailing earnings, 1.8× forward earnings and 1.5× sales. Over the trailing twelve months it earned $187.17M on revenue of $462.25M (a 40.5% profit margin) and generated $250.42M of free cash flow. Revenue grew 280.5% year over year.
As of its latest reported balance sheet, it holds $256.69M in cash and securities against $145.15M of debt, a net cash position of $111.54M.
CorMedix does not currently pay a dividend.
The share price is down 26.7% over the past year. At $7.26 (the Oct 16, 2026 close) it sits within its 52-week range of $6.13 to $13.02, below its 200-day moving average of $7.82.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $14.25, 96.3% above the Oct 16, 2026 close.
Frequently Asked Questions About CorMedix
What is the current stock price for CRMD?
As of the Oct 16, 2026 close, CRMD stock trades at $7.26. The 52-week range is $6.13–$13.02, with a day range of $7.24–$7.47.
What is the P/E ratio for CRMD?
As of the Oct 16, 2026 close, CorMedix's trailing twelve-month (TTM) P/E ratio is 3.7, meaning investors pay $3.7 for every $1 of annual earnings. The forward P/E is 1.8, reflecting analyst expectations for future earnings. CorMedix operates in the Healthcare sector.
Does CRMD pay dividends?
CorMedix does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRMD?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for CRMD is Buy. The average 12-month price target is $14.25, a 96.3% upside from the Oct 16, 2026 close of $7.26.
What is the market cap of CRMD?
As of the Oct 16, 2026 close, CorMedix's market capitalization is $671.4M, classifying it as a small-cap company. CorMedix operates in the Healthcare sector within the Biotechnology industry.